Moderna (MRNA) News Today $57.31 -0.42 (-0.73%) (As of 10/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Moderna (NASDAQ:MRNA) PT Lowered to $55.00Jefferies Financial Group cut their price target on shares of Moderna from $65.00 to $55.00 and set a "hold" rating for the company in a research note on Tuesday.October 15 at 1:54 PM | marketbeat.comGlaxoSmithKline sues Moderna for US patent infringement over COVID vaccinesOctober 15 at 10:20 AM | reuters.commRNA Therapeutics Industry Research 2024-2028 & Long-term Forecast to 2033: Emerging Self-Amplifying mRNA Platforms, Scalability and Flexibility Expected to Revolutionize Vaccine DevelopmentOctober 15 at 4:03 AM | globenewswire.commRNA Cancer Vaccines and Therapeutics Research Report 2024 with Long-term Forecasts to 2028 and 2033: Personalized Medicine and Multivalent mRNA Vaccines Lead the WayOctober 14 at 11:48 AM | globenewswire.comPolianta Ltd Takes Position in Moderna, Inc. (NASDAQ:MRNA)Polianta Ltd bought a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 12,500 shares of the company's stock, valued at apOctober 14 at 8:01 AM | marketbeat.comCompagnie Lombard Odier SCmA Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)Compagnie Lombard Odier SCmA lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 7.2% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 128,304 shares of the company's stock after selling 9,982 shares during the quarter. CompagnieOctober 13 at 1:28 PM | marketbeat.com2 Biotech Stocks That Are Screaming Buys This MonthOctober 12, 2024 | fool.comCwm LLC Sells 24,084 Shares of Moderna, Inc. (NASDAQ:MRNA)Cwm LLC reduced its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 14.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,190 shares of the company's stock after selling 24,084 shares duringOctober 12, 2024 | marketbeat.comTobam Acquires 15,249 Shares of Moderna, Inc. (NASDAQ:MRNA)Tobam raised its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 121.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 27,794 shares of the company's stock after acquiring an additional 15,249 shares during the quarter. Tobam's holdingsOctober 10, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Reaches New 52-Week Low - Here's What HappenedOctober 10, 2024 | americanbankingnews.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ModernaOctober 9, 2024 | markets.businessinsider.comJames M. Mock Sells 715 Shares of Moderna, Inc. (NASDAQ:MRNA) StockOctober 9, 2024 | insidertrades.comModerna, Inc. (NASDAQ:MRNA) CFO James M. Mock Sells 715 SharesOctober 8, 2024 | americanbankingnews.comThe Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRNAOctober 8, 2024 | globenewswire.comMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law FirmOctober 8, 2024 | businesswire.comGSK Reports Sustained Efficacy of RSV Vaccine Amidst Competition from Pfizer and ModernaOctober 8, 2024 | gurufocus.comModerna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNAOctober 8, 2024 | prnewswire.comStocks on Sale, Novavax, Moderna, and MoreOctober 7, 2024 | baystreet.caMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law FirmOctober 7, 2024 | prnewswire.comShareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNAOctober 7, 2024 | prnewswire.comSG Americas Securities LLC Sells 93,306 Shares of Moderna, Inc. (NASDAQ:MRNA)SG Americas Securities LLC lessened its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 63.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 52,779 shares of the company's stock after selling 93,306 sOctober 7, 2024 | marketbeat.comCoinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?October 6, 2024 | benzinga.comMRNA DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Moderna, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNAOctober 6, 2024 | globenewswire.comMRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their RightsOctober 5, 2024 | businesswire.comJim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’October 5, 2024 | msn.comMRNA Deadline: MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud LawsuitOctober 4, 2024 | prnewswire.comGlobal mRNA Cancer Vaccine Clinical Trial FDA Approval Market Size Future Opportunity Companies InsightOctober 4, 2024 | globenewswire.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Dana Investment Advisors Inc.Dana Investment Advisors Inc. trimmed its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,788 shares of the company's stock after selOctober 4, 2024 | marketbeat.comIMPORTANT MRNA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNAOctober 3, 2024 | globenewswire.comAlnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 VaccineOctober 3, 2024 | msn.comModerna (NASDAQ:MRNA) Sets New 1-Year Low at $62.20Moderna (NASDAQ:MRNA) Hits New 12-Month Low at $62.20October 3, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNAOctober 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNAOctober 3, 2024 | prnewswire.comModerna fends off Alnylam US patent lawsuit over COVID shots, for nowOctober 3, 2024 | reuters.comMarshall Wace LLP Has $4.18 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA)Marshall Wace LLP boosted its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 295.5% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,200 shares of the company's stock after purchasing an additional 26,300 shares during the period. MarOctober 3, 2024 | marketbeat.comOctober 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNAOctober 2, 2024 | globenewswire.comIs It Time to Buy September's Worst-Performing S&P 500 Stocks?October 2, 2024 | fool.comModerna doses first subject in Phase III trial of mRNA norovirus vaccine in USOctober 1, 2024 | msn.comIs Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?October 1, 2024 | msn.comModerna, Inc. Class Action: Levi & Korsinsky Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNAOctober 1, 2024 | prnewswire.comModerna, Inc. (NASDAQ:MRNA) Shares Purchased by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky increased its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 4.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 283,909 shares of the company's stock after acquiring aOctober 1, 2024 | marketbeat.comModerna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights – MRNASeptember 30, 2024 | globenewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNASeptember 30, 2024 | globenewswire.comMRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSeptember 30, 2024 | prnewswire.comSusquehanna Fundamental Investments LLC Takes Position in Moderna, Inc. (NASDAQ:MRNA)Susquehanna Fundamental Investments LLC acquired a new stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 33,987 shares of the company's stock, vaSeptember 30, 2024 | marketbeat.comMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud LawsuitSeptember 29, 2024 | prnewswire.comMove Over, mRNA: What to Know About the Novavax COVID VaccineSeptember 29, 2024 | msn.comFaruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNASeptember 29, 2024 | prnewswire.comModerna, Inc. (NASDAQ:MRNA) Stock Holdings Lowered by Legal & General Group PlcLegal & General Group Plc cut its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 6.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,616,531 shares of the company's stock after selling 186,341 sharSeptember 29, 2024 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Receives Average Rating of "Hold" from BrokeragesShares of Moderna, Inc. (NASDAQ:MRNA - Get Free Report) have earned a consensus recommendation of "Hold" from the nineteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, thirteen have assignedSeptember 29, 2024 | marketbeat.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future. Take these 4 steps today to protect your retirement NOW MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.370.80▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼1521▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Biogen News Bio-Techne News Neurocrine Biosciences News Repligen News Denali Therapeutics News CRISPR Therapeutics News GSK News Takeda Pharmaceutical News BioNTech News BeiGene News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 10/16/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNA Stock Alerts